autologous anti-CD30 CAR T cells HSP-CAR30
Term · Oncology and biomedicine · MLC-T-ONC-011397
A preparation of autologous T lymphocytes that have been genetically modified to express a chimeric antigen receptor (CAR) specific for the CD30 antigen, with potential immunostimulating and antineoplastic activities. Upon administration, autologous anti-CD30 CAR T cells HSP-CAR30 specifically recognize and bind to CD30-expressing tumor cells, resulting in tumor cell lysis. CD30, a cell surface receptor and a member of the tumor necrosis factor (TNF) receptor superfamily, is transiently expressed on activated lymphocytes and is constitutively expressed in hematologic malignancies.
| Identifier | MLC-T-ONC-011397 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | autologous CD30-targeting CAR T cells HSP-CAR30 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011397",
"term": "autologous anti-CD30 CAR T cells HSP-CAR30",
"field": "Oncology and biomedicine",
"definition": "A preparation of autologous T lymphocytes that have been genetically modified to express a chimeric antigen receptor (CAR) specific for the CD30 antigen, with potential immunostimulating and antineoplastic activities. Upon administration, autologous anti-CD30 CAR T cells HSP-CAR30 specifically recognize and bind to CD30-expressing tumor cells, resulting in tumor cell lysis. CD30, a cell surface receptor and a member of the tumor necrosis factor (TNF) receptor superfamily, is transiently expressed on activated lymphocytes and is constitutively expressed in hematologic malignancies.",
"synonyms": [
"autologous CD30-targeting CAR T cells HSP-CAR30"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/autologous-anti-cd30-car-t-cells-hsp-car30/"
}
Record 2,729 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.